title: Tiotropium safety in 'real-world' populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Wise
authors.affiliation: University of Texas and South Texas Veterans Health Care System, San Antonio, TX, USA.
authors.forename: Antonio
authors.initials: A
authors.lastname: Anzueto
authors.affiliation: Odense University Hospital, Odense C, Denmark.
authors.forename: Ronald
authors.initials: R
authors.lastname: Dahl
authors.affiliation: Service de Pneumologie Hôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Dusser
authors.affiliation: Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Calverley
mesh_terms: D001993:Bronchodilator Agents; D006801:Humans; D010601:Pharmacology, Clinical; D029424:Pulmonary Disease, Chronic Obstructive; D000069447:Tiotropium Bromide
chemical_list: D001993:Bronchodilator Agents; D000069447:Tiotropium Bromide